-
1
-
-
44149084718
-
Antiretroviral therapy and central nervous system HIV type 1 infection
-
Price RW, Spudich S. Antiretroviral therapy and central nervous system HIV type 1 infection. J Infect Dis 2008;197:S294-S306
-
(2008)
J Infect Dis
, vol.197
-
-
Price, R.W.1
Spudich, S.2
-
2
-
-
34548208844
-
The prevalence and incidence of neurocognitive impairment in the HAART era
-
Robertson KR, Smurzynski M, Parsons TD, et al. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS 2007;21:1915-21
-
(2007)
AIDS
, vol.21
, pp. 1915-1921
-
-
Robertson, K.R.1
Smurzynski, M.2
Parsons, T.D.3
-
3
-
-
66749103433
-
The transport of anti-HIV drugs across blood-CNS interfaces: Summary of current knowledge and recommendations for further research
-
Varatharajana L, Thomas SA. The transport of anti-HIV drugs across blood-CNS interfaces: summary of current knowledge and recommendations for further research. Antiviral Res 2009;82:A99-A109
-
(2009)
Antiviral Res
, vol.82
-
-
Varatharajana, L.1
Thomas, S.A.2
-
4
-
-
34247583029
-
Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes
-
Nachega JB, Hislop M, Dowdy DW, et al. Adherence to nonnucleoside reverse transcriptase inhibitor-based HIV therapy and virologic outcomes. Ann Intern Med 2007;146:564-73
-
(2007)
Ann Intern Med
, vol.146
, pp. 564-573
-
-
Nachega, J.B.1
Hislop, M.2
Dowdy, D.W.3
-
5
-
-
0034027217
-
Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population
-
Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS 2000;14:357-66
-
(2000)
AIDS
, vol.14
, pp. 357-366
-
-
Bangsberg, D.R.1
Hecht, F.M.2
Charlebois, E.D.3
-
6
-
-
0016823810
-
'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician
-
Folstein MF, Folstein SE, McHugh PR. 'Mini-mental state'. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-98
-
(1975)
J Psychiatr Res
, vol.12
, pp. 189-198
-
-
Folstein, M.F.1
Folstein, S.E.2
McHugh, P.R.3
-
7
-
-
0031041375
-
In vivo compartmentalization of human immunodeficiency virus: Evidence from the examination of pol sequences from autopsy tissues
-
Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 1997;71:2059-71
-
(1997)
J Virol
, vol.71
, pp. 2059-2071
-
-
Wong, J.K.1
Ignacio, C.C.2
Torriani, F.3
Havlir, D.4
Fitch, N.J.5
Richman, D.D.6
-
8
-
-
13744263272
-
Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy
-
Strain MC, Letendre S, Pillai SK, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J. Virol 2005;79:1772-88
-
(2005)
J. Virol
, vol.79
, pp. 1772-1788
-
-
Strain, M.C.1
Letendre, S.2
Pillai, S.K.3
-
9
-
-
1542345591
-
Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance
-
Bestetti A, Presi S, Pierotti C, et al. Long-term virological effect of highly active antiretroviral therapy on cerebrospinal fluid and relationship with genotypic resistance. J Neurovirol 2004;10(suppl 1):52-7
-
(2004)
J Neurovirol
, vol.10
, Issue.SUPPL. 1
, pp. 52-57
-
-
Bestetti, A.1
Presi, S.2
Pierotti, C.3
-
10
-
-
38349068747
-
Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system
-
Letendre S, Marquie-Beck J, Capparelli E, et al. Validation of the CNS penetration-effectiveness rank for quantifying antiretroviral penetration into the central nervous system. Arch Neurol 2008;65:65-70
-
(2008)
Arch Neurol
, vol.65
, pp. 65-70
-
-
Letendre, S.1
Marquie-Beck, J.2
Capparelli, E.3
-
12
-
-
0034622946
-
Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid
-
Cunningham PH, Smith DG, Satchell C, Cooper DA, Brew B. Evidence for independent development of resistance to HIV-1 reverse transcriptase inhibitors in the cerebrospinal fluid. AIDS 2000;14:1949-54
-
(2000)
AIDS
, vol.14
, pp. 1949-1954
-
-
Cunningham, P.H.1
Smith, D.G.2
Satchell, C.3
Cooper, D.A.4
Brew, B.5
-
13
-
-
0033179067
-
Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1-infected patients
-
Chien JW, Valdez H, McComsey G, McClernon D, St Clair M, Lederman MM. Presence of mutation conferring resistance to lamivudine in plasma and cerebrospinal fluid of HIV-1-infected patients. J Acquir Immune Defic Syndr 1999;21:277-80
-
(1999)
J Acquir Immune Defic Syndr
, vol.21
, pp. 277-280
-
-
Chien, J.W.1
Valdez, H.2
McComsey, G.3
McClernon, D.4
St Clair, M.5
Lederman, M.M.6
-
14
-
-
0034048862
-
Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples
-
Venturi G, Catucci M, Romano L, et al. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis 2000;181:740-5
-
(2000)
J Infect Dis
, vol.181
, pp. 740-745
-
-
Venturi, G.1
Catucci, M.2
Romano, L.3
|